Foresite Capital Management Vi Llc Portfolio Stock Holdings
Foresite Capital Management Vi Llc disclosed 17 stock positions valued at approximately $460.3 million in its latest SEC 13F filing. The largest holdings include CG Oncology, Inc., ALUMIS INC., and Centessa Pharmaceuticals plc. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 17
- Portfolio Value
- $460.3M
Holdings by Sector
Foresite Capital Management Vi Llc Portfolio Holdings in Q1 2026
12 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| CG Oncology, Inc. | CGON | Healthcare | 32.67% | 2,221,474 | - | - | $150,349,360 |
| ALUMIS INC. | ALMS | Healthcare | 20.33% | 4,247,670 | - | - | $93,576,170 |
| Centessa Pharmaceuticals plc | CNTA | Healthcare | 11.77% | 1,364,019 | - | - | $54,178,835 |
| Corvus Pharmaceuticals, Inc. | CRVS | Healthcare | 5.82% | 1,831,233 | +450,000 | +32.58% | $26,790,939 |
| Denali Therapeutics Inc. | DNLI | Healthcare | 5.05% | 1,209,971 | +209,971 | +21.00% | $23,231,443 |
| AGIOS PHARMACEUTICALS, INC. | AGIO | Healthcare | 3.86% | 525,000 | -5,000 | -0.94% | $17,760,750 |
| Verastem, Inc. | VSTM | Healthcare | 3.62% | 3,146,631 | +11,511 | +0.37% | $16,677,144 |
| Kymera Therapeutics, Inc. | KYMR | Healthcare | 2.65% | 146,332 | - | - | $12,187,992 |
| Minerva Neurosciences, Inc. | NERV | Healthcare | 2.60% | 1,986,600 | +1,986,600 | +100.00% | $11,969,265 |
| Celldex Therapeutics, Inc. | CLDX | Healthcare | 2.18% | 315,913 | +315,913 | +100.00% | $10,020,760 |
| Hinge Health, Inc. | 433313103 | Other | 1.85% | 220,400 | +85,400 | +63.26% | $8,498,624 |
| Crinetics Pharmaceuticals, Inc. | CRNX | Healthcare | 1.67% | 212,010 | +212,010 | +100.00% | $7,700,203 |